rs142977595

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001089.3(ABCA3):​c.371A>G​(p.Asn124Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00136 in 1,610,770 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00082 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 4 hom. )

Consequence

ABCA3
NM_001089.3 missense

Scores

1
4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 4.84

Publications

7 publications found
Variant links:
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]
ABCA3 Gene-Disease associations (from GenCC):
  • interstitial lung disease due to ABCA3 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2047585).
BP6
Variant 16-2324480-T-C is Benign according to our data. Variant chr16-2324480-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 504721.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000822 (125/152024) while in subpopulation AMR AF = 0.00157 (24/15260). AF 95% confidence interval is 0.00108. There are 0 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA3NM_001089.3 linkc.371A>G p.Asn124Ser missense_variant Exon 6 of 33 ENST00000301732.10 NP_001080.2 Q99758-1Q4LE27

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA3ENST00000301732.10 linkc.371A>G p.Asn124Ser missense_variant Exon 6 of 33 1 NM_001089.3 ENSP00000301732.5 Q99758-1
ABCA3ENST00000382381.7 linkc.371A>G p.Asn124Ser missense_variant Exon 6 of 32 1 ENSP00000371818.3 H0Y3H2
ABCA3ENST00000567910.1 linkc.371A>G p.Asn124Ser missense_variant Exon 5 of 6 1 ENSP00000454397.1 Q99758-2
ABCA3ENST00000563623.5 linkn.934A>G non_coding_transcript_exon_variant Exon 6 of 20 1

Frequencies

GnomAD3 genomes
AF:
0.000823
AC:
125
AN:
151906
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00122
Gnomad OTH
AF:
0.000960
GnomAD2 exomes
AF:
0.00108
AC:
268
AN:
248206
AF XY:
0.00105
show subpopulations
Gnomad AFR exome
AF:
0.000248
Gnomad AMR exome
AF:
0.000666
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00143
Gnomad NFE exome
AF:
0.00175
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00141
AC:
2062
AN:
1458746
Hom.:
4
Cov.:
31
AF XY:
0.00143
AC XY:
1035
AN XY:
725674
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33478
American (AMR)
AF:
0.000984
AC:
44
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26120
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.000290
AC:
25
AN:
86204
European-Finnish (FIN)
AF:
0.00190
AC:
96
AN:
50468
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00166
AC:
1843
AN:
1111936
Other (OTH)
AF:
0.000679
AC:
41
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
129
259
388
518
647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000822
AC:
125
AN:
152024
Hom.:
0
Cov.:
31
AF XY:
0.000740
AC XY:
55
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41462
American (AMR)
AF:
0.00157
AC:
24
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4794
European-Finnish (FIN)
AF:
0.000661
AC:
7
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00122
AC:
83
AN:
67986
Other (OTH)
AF:
0.000950
AC:
2
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.00121
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.00124
AC:
151
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00148

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Interstitial lung disease due to ABCA3 deficiency Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Hereditary pulmonary alveolar proteinosis Uncertain:1
Feb 26, 2018
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.N124S variant (also known as c.371A>G), located in coding exon 3 of the ABCA3 gene, results from an A to G substitution at nucleotide position 371. The asparagine at codon 124 is replaced by serine, an amino acid with highly similar properties. A study of the N-linked glycosylation site at residue 124 found that single mutations at the glycosylation site fail to disrupt the trafficking pattern of ABCA3 to cytosolic lysosomal-related organelles or alter their function as lipid transporters (Beers MF et al. Am. J. Physiol. Lung Cell Mol. Physiol., 2013 Dec;305:L970-80). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on available evidence to date, the clinical significance of this alteration remains unclear. -

not specified Benign:1
Jan 22, 2019
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Asn124Ser variant in ABCA3 is classified as likely benign because it has has been identified in 0.16% (209/128312) of European and 0.13% (32/23120) of Finnish chromosomes including 1 homozygote by gnomAD (http://gnomad.broadinstitute.org), and because computational prediction tools and conservation analysis suggest that the variant may not impact the protein. ACMG/AMP criteria applied: BS1_Supporting, BP4. -

not provided Benign:1
Nov 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
20
DANN
Benign
0.96
DEOGEN2
Benign
0.21
T;.;.
Eigen
Benign
0.11
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Pathogenic
0.32
D
MetaRNN
Benign
0.20
T;T;T
MetaSVM
Uncertain
0.51
D
MutationAssessor
Benign
1.6
L;.;L
PhyloP100
4.8
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.6
N;N;N
REVEL
Uncertain
0.43
Sift
Benign
0.28
T;T;T
Sift4G
Benign
0.72
T;T;T
Polyphen
0.20
B;.;.
Vest4
0.79
MVP
0.89
MPC
0.27
ClinPred
0.042
T
GERP RS
5.4
Varity_R
0.063
gMVP
0.37
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142977595; hg19: chr16-2374481; API